3 May 2021 - Deborah Wilkes
Premium
GlaxoSmithKline (GSK) Consumer Healthcare reported a significant drop in sales during the first quarter of 2021 as divestments and the COVID-19 pandemic took their toll.
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.